| 1 |
32807064 | Synthesis and Evaluation of Cytotoxicity of Novel Coumarin Peptide Alcohol Derivatives. | 2021 |
1 |
| 2 |
29045135 | Structural Basis of Inhibition of ERĪ±-Coactivator Interaction by High-Affinity N-Terminus Isoaspartic Acid Tethered Helical Peptides. | 2017 Nov 9 |
1 |
| 3 |
26848530 | Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer. | 2016 Mar 1 |
1 |
| 4 |
16179380 | Altered target gene regulation controlled by estrogen receptor-alpha concentration. | 2006 Feb |
2 |
| 5 |
16191480 | Targeted mutation of key residues at the start of helix 12 in the hERalpha ligand-binding domain identifies the role of hydrogen-bonding and hydrophobic interactions in the activity of the protein. | 2006 Jan |
2 |
| 6 |
16679488 | Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha. | 2006 Aug |
1 |
| 7 |
15965534 | Identification of the estrogen receptor Cd-binding sites by chemical modification. | 2005 Jul |
1 |
| 8 |
16326832 | Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha. | 2005 Dec |
7 |
| 9 |
15604293 | Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. | 2004 Dec 15 |
1 |
| 10 |
12496244 | Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12. | 2003 Feb 28 |
1 |
| 11 |
12790809 | Transcriptional activation by estrogen receptor (ERalpha) and steroid receptor coactivator (SRC1) involves distinct mechanisms in yeast and mammalian cells. | 2003 Jun |
2 |
| 12 |
11751902 | Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells. | 2002 Mar 15 |
4 |
| 13 |
11159857 | Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen. | 2001 Feb |
2 |
| 14 |
10787412 | Aspartate 351 of estrogen receptor alpha is not crucial for the antagonist activity of antiestrogens. | 2000 Jul 7 |
3 |
| 15 |
9581827 | The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor. | 1998 May 1 |
1 |
| 16 |
9219916 | Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor. | 1997 Mar |
1 |
| 17 |
7476979 | A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog. | 1995 Aug |
2 |